The public COA is shown in English and kept in its original laboratory form. Internal self-inspection COAs are private.
Muscle growth & growth hormone
CJC-1295 with DAC research material is available in 5mg, 10mg. Select the required specification below. The displayed amount is the price per vial; orders start at 10 vials and increase in multiples of 10.
CJC-1295 with DAC research material is available in 5mg, 10mg. Select the required specification below. The displayed amount is the price per vial; orders start at 10 vials and increase in multiples of 10.
LYSENTA research catalogue
Description
CJC-1295 with DAC research material is available in 5mg, 10mg. Select the required specification below. The displayed amount is the price per vial; orders start at 10 vials and increase in multiples of 10.
Supplied strictly as laboratory research material. Record the selected SKU, batch and COA in the research workflow.
Frequently asked questions
The displayed price is per vial. The spreadsheet box price has been divided by 10 without changing its total: selecting 10 vials equals one full box.
The minimum is 10 vials, and every additional quantity must be a multiple of 10.
When available, the public English COA is linked to the selected specification. Internal self-inspection COAs remain private in the administration area.
This material is supplied strictly for laboratory and research use and is not intended for human or animal use.
RESEARCH & QUALITY DOCUMENTATION
Content updated · English reference edition
CJC-1295 with DAC is listed separately from the no-DAC product in this catalogue. The distinction matters when locating the literature and selecting a research comparator. A similar name does not make two molecular forms interchangeable. This page provides a starting reference for the long-acting analogue and highlights the identity questions that should be resolved before an experimental comparison.
Early randomized human studies — long-acting CJC-1295 analogue
Teichman and colleagues reported two randomized studies of the long-acting GHRH analogue CJC-1295 in healthy adults in 2006. Their outcomes included growth hormone, IGF-I and pharmacokinetic measurements. The findings refer to that investigated compound and protocol. They should not be transferred to a no-DAC material or used to infer the clinical safety, effectiveness or identity of a catalogue vial.
Reference: Teichman et al., 2006 — long-acting CJC-1295 in healthy adults ↗
Check explicitly for the DAC designation when comparing CJC-1295 listings and documents. No-DAC terminology is commonly associated with modified GRF products, but the exact identity must still be confirmed. Neither a shared category nor a similar product name is sufficient evidence that two preparations match the compound used in a paper.
Match the selected DAC specification, SKU and supplied lot to its analytical documentation. Ask for the stated molecular form and identity method before interpreting the purity result. If a report belongs to a no-DAC specification or a combination product, it should not be used as evidence for this single-compound DAC listing.
No interchangeability is implied. They are separate catalogue entries, and their molecular forms must be checked before selecting literature or comparing experimental results.
Do not assume that it does. The linked study concerns the long-acting analogue; conclusions should remain tied to the compound and protocol investigated.
No. A blend is a different composition. Use documentation that matches this specification and verify the intended supplied lot with support.
Sources describe the materials and conditions studied by their authors. They are not endorsements of LYSENTA or certificates for the products on this website.
Related does not mean interchangeable. Check composition and evidence separately.
Browse all research and documentation guides →
For laboratory research only. Not for human or animal use. No clinical dosing, treatment or administration advice is provided.
SAME CATEGORY
